中国比较医学杂志2026，Vol.36Issue(7)：125-136,12.DOI:10.3969/j.issn.1671-7856.2026.07.011
异甘草素抗癌的研究进展
Advances in anticancer effects of isoliquiritigenin
摘要
Abstract
Cancer is the second leading cause of death worldwide.Despite significant recent progress in the treatment of cancer,the incidence and mortality rate are still high,and finding effective drugs to treat cancer thus remains a focus of research.The natural compound extract,isoliquiritigenin(ISL),has been widely studied in terms of its anti-tumor effects in recent years.This article reviews recent research progress on the anti-cancer effects of ISL,and discusses its role in suppressing the occurrence of cancer by controlling the cell cycle,metastasis,angiogenesis,cell death,and the immune system.Among these mechanisms,ISL suppresses the development of cancer through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin,epidermal growth factor receptor/extracellular signal-regulated kinase 1/2,and signal transducer and activator of transcription 3 pathways.In addition,we also consider the roles of ISL in combination with first-line anticancer drugs and the anti-tumor properties of its nano-preparations.关键词
癌症/异甘草素/信号通路Key words
cancer/isoliquiritigenin/signaling pathway分类
医药卫生引用本文复制引用
沈莹雪,董文杰,贾彦彬..异甘草素抗癌的研究进展[J].中国比较医学杂志,2026,36(7):125-136,12.基金项目
内蒙古自然科学基金(2024MS08079) （2024MS08079）
包头医学院创新团队(bycxtd-06). （bycxtd-06）
